Aegerion Pharmaceuticals, Inc. acquisition of certain assets of Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP | Practical Law

Aegerion Pharmaceuticals, Inc. acquisition of certain assets of Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP | Practical Law

Aegerion Pharmaceuticals, Inc. acquisition of certain assets of Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP

Aegerion Pharmaceuticals, Inc. acquisition of certain assets of Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP

November 05, 2014Private Acquisition Agreements$325 million
End of Document

© 2024 Thomson Reuters. No claim to original U.S. Government Works.